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Short title: Propionibacterium avidum hip PJI 
 
Summary 
We describe 13 periprosthetic joint infections caused by Propionibacterium avidum. 
The majority were hip-associated and occurred after hip arthroplasty surgery using 
an anterior surgical approach. Upon phylogenetic analysis, isolated strains clustered 
with P. avidum PJI strains from Sweden. 
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Abstract 
Background. Propionibacteria are important members of the human skin microbiota, 
but are also opportunistic pathogens associated with periprosthetic joint infections 
(PJI). While the role of Propionibacterium acnes in PJI has been widely described, 
insight into the capacity of Propionibacterium avidum to cause PJI is limited. 
Methods. An unusual cluster of four hip PJIs caused by P. avidum in one orthopedic 
center in 2015 prompted us to retrospectively identify and analyze clinical data 
related to previous P. avidum PJI cases (1997-2015). We also characterized the 
hemolytic and biofilm-producing capacity of our four clinical P. avidum strains isolated 
in 2015, and investigated their phylogenetic relationships by whole genome 
sequencing. 
Results. We retrospectively identified 13 P. avidum PJIs, with the majority being hip-
related infections (n=11). Preoperative synovial fluid cultures were P. avidum positive 
in 63.6% of cases. Six out of 12 patients (50%) with available case histories were 
treated with an exchange of the prosthesis. In all but one of the six patients treated 
with debridement-retention of the prosthesis, treatment failed thus requiring a two-
stage revision. The isolated P. avidum strains showed a more pronounced hemolytic 
activity, but a similar biofilm-forming ability when compared to P. acnes. Whole 
genome sequencing identified two phylogenetic clusters highly related to P. avidum 
PJI strains isolated in Sweden.  
Conclusions. We describe the largest series of P. avidum PJI predominantly located 
in the hip.  
Phylogenetic similarity of our P. avidum strains to PJI strains isolated elsewhere 
suggests these invasive lineages may be common. 
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Introduction 
Periprosthetic joint infections (PJI) following prosthesis implantation result in high 
morbidity [1]. The incidence is rising due to the increasing life span of our population 
resulting in high numbers of degenerative disorders requiring joint replacements. The 
most commonly isolated microorganisms in PJI are staphylococci., followed by 
streptococci., enterococci., Gram-negative bacteria and anaerobes [2].  
Propionibacteria are Gram-positive anaerobic bacteria and integral 
components of the normal human skin microbiota, but also cause opportunistic 
infections including PJI [3]. Of the three members of the cutaneous group of human 
propionibacteria, Propionibacterium acnes is by far the most frequent cause of PJI. 
Individual case reports of soft tissue and medical device-related infections due to 
Propionibacterium avidum (recently proposed as Cutibacterium avidum) and, even 
less commonly, Propionibacterium granulosum have been described [7-14]. 
In 2015, we identified and treated a cluster of four patients with P. avidum PJIs 
occurring within a single orthopedic center. Due to this unusual observation, we 
decided to conduct a wider, and much needed, epidemiological and clinical 
assessment of patients with P. avidum PJI for potential risk factors and treatment 
outcomes. We also investigated P. avidum PJI strains for key virulence properties, 
and performed whole genome analysis to examine their phylogenetic relationship to 
one another, as well as a small number of previously sequenced strains isolated from 
PJIs.  
 
Materials and Methods 
Patients and Study design  
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The Department of Orthopedics of the University Hospital Balgrist is a specialized 
tertiary care hospital with 120 beds. In 2015, approximately 5,000 surgical 
procedures were performed, of which 326 procedures were primary hip 
arthroplasties. In 2015, we prospectively identified four patients with a hip P. avidum 
PJI. Clinical and epidemiological patient’s history was retrieved from the 
prospectively managed database on all infections from the Infectious Diseases 
Consulting Service, and from the hospital clinical information system. We also 
conducted a retrospective analysis of the microbiological laboratory database of the 
Institute of Medical Microbiology, University of Zurich, to identify further P. avidum 
infections at the University Hospital Balgrist (1997-2014). The clinical presentation of 
the patients with P. avidum isolated in tissue, synovial or sonicated fluid was 
reviewed. Infection was differentiated from contamination when P. avidum grew in at 
least two biopsy or sonication fluid samples [4]. We calculated the in-hospital 
incidence of P. avidum PJI as the number of P. avidum PJI divided by number of total 
surgeries per year performed at the clinic Balgrist, taking into account the increasing 
number of primary implantation of arthroplasties or revision surgeries in recent years. 
Basic characteristics, clinical presentation at the time of diagnosis, diagnostic steps 
according to MSIS criteria [5], surgical and antibiotic treatment, and outcome of PJI 
were analyzed.  
Potential risk factors such as an association with a particular surgeon, 
changing the surgical incision approach, antibiotic prophylaxis or patient BMI were 
studied. The surgical incision approach used in hip arthroplasty surgeries was 
changed from lateral to anterior in 2006. As a result, infection rate before and after 
introduction of this change was investigated to identify whether the surgical approach 
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used was a potential risk factor. Perioperative intravenous antibiotic prophylaxis with 
cefuroxime 1.5g was routinely administered 30-60 minutes prior to skin incision, 
followed by two additional doses. Skin was disinfected three times with a povidone-
iodine solution (BetasepticTM) throughout the entire study period.  
The cantonal ethic authority of Zurich, Switzerland approved the study protocol 
(KEK Nr. 2016-00145 and Nr. 2015-0357).  
 
Bacteriology 
Microbiological techniques and standard biochemical methods for the detection and 
identification of Propionibacterium species were performed as previously described 
[6]. In short, incubation time for synovial fluid and sonication fluid was seven days 
and 10 days for tissue biopsies. Diagnosis of P. avidum included a positive reaction 
for catalase, CAMP factor, and esculin, and a negative test for indole to distinguish 
from other Propionibacterium spp. [7] From 2012, strains were identified using matrix-
assisted laser desorption ionization-time of flight mass spectrometry spectrometry 
(MALDI-TOF MS) using a Bruker MALDI Biotyper in combination with research-use-
only (RUO) versions of the MALDI Biotyper software package (version 3.0) and the 
reference database V.3.3.1.0 (4613 entries) or later database versions. When 
ordered by the Infectious Diseases specialist, antibiotic susceptibility testing was 
performed using E-test strips (Bio-Mérieux) on Brucella agar plates (McFarland 0.5) 
cultivated for 48 hours. 
 
Bacterial strains 
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A total of five strains isolated from four patients in 2015 [clinical isolate (CI) 828, 853, 
878, 882, 855] were analyzed. We also examined four randomly selected clinical P. 
acnes strains (CI803, CI805, CI806, CI820) from our bacterial biobank for 
comparison of hemolytic activity. To compare P. avidum with P. acnes for biofilm 
formation we used P. acnes strain ATCC 11827, which is known to adhere to foreign 
materials and produce biofilms in vivo [8, 9].  
 
Hemolysis and biofilm formation. 
Zones of hemolysis were measured (in mm) on Brucella agar plates. Biofilm 
formation was measured in vitro using a microtiter plate assay [10]. The results were 
compared to those obtained with the P. acnes strain ATCC 11827. The ratio of 
biofilm mass over total biomass of P. acnes and P. avidum, respectively were 
calculated. 
 
Whole genome sequencing and phylogenetic analyses 
Genomic DNA was extracted from P. avidum cultures using a QIAamp DNA Micro Kit 
(Qiagen) according to the manufacturer’s instructions. Sequencing libraries were 
prepared using a NexteraXT library kit (Illumina), pooled and then sequenced on an 
Illumina MiSeq. Paired-end sequencing reads of 300-bp were assembled using MIRA 
v4.0.2 [11], and the assemblies were manually refined using Consed and Gap5 [12]. 
Core genomic regions shared by all analyzed P. avidum strains were compared as 
described [13] using Nucmer [14]. The core SNP sites were concatenated and 
imported into MEGA5 [15] for phylogenetic tree analysis. 
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 Comparison of the exopolysaccharide (EPS) encoding locus in P. avidum 
strains was performed using Nucmer; the 35-kb EPS region previously described in 
the strain T13 [16] was aligned against all P. avidum genomes. Homologous regions 
identified in each strain were manually assembled with Gap5 [12] using the T13 
region as reference, and the resulting scaffolds were then aligned with MAFFT [17] 
for phylogenetic analysis in MEGA7. 
 
Statistical analysis 
Wilcoxon rank-sum tests were used to compare continuous variables and Fisher's 
exact test to compare categorical variables.  
 
Results 
Cohort of P. avidum PJI cases 
In 2015, we identified a cluster of four P. avidum PJIs that occurred after primary hip 
arthroplasty surgery, which was conducted via an anterior approach. Retrospective 
analysis of our microbiological database identified an additional nine patients with a 
PJI due to P. avidum, and two patients with osteomyelitis and a soft-tissue infection 
due to P. avidum (all between January 1997 and December 2014). Of the 13 PJIs 
(four prospectively, nine retrospectively), 11 were hip (84.6%) and two shoulder-
related (Figure 1).  
Arthroplasty surgery was performed by 13 surgical teams in six operating 
theatres excluding an association between post-surgical infection and a specific 
surgeon or team. Only eight patients had surgery on the same joint preceding 
infection at the University Hospital Balgrist –labeled as ‘in-house acquired infection’. 
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Among them, hip arthroplasties were more affected than shoulder (seven hip 
infections of a total of 6,860 surgeries [0.10%]) versus one shoulder infection of a 
total of 1963 surgeries [0.04%] between 1997 and 2015. For hip arthroplasty, the 
standard surgical incision approach changed from lateral to anterior in 2006 within 
our clinic. We observed a lower ratio of postoperative infections compared to the 
number of total surgeries of 0.04% (1/2262) during the time period before changing 
the incision approach (1997-2005), as compared to 0.13% (6/4598) after the new 
approach was adopted (2006-2015). The risk for a postsurgical infection was 2.95 
times higher in the latter time period (RR = 2.95, 95%CI 0.36 – 24.5, p =0.44). Except 
for the additional routine use of tranexamic acid since 2005, no hospital hygiene 
procedures (type of irrigation, skin cleansing, ventilation system) had been changed 
during the observed period. All patients routinely received perioperative antibiotic 
prophylaxis with cefuroxime. 
One of the patients had a P. avidum PJI in 1997. Since the medical history records of 
this patient no longer exist, this patient was excluded from further analysis. Thus, we 
describe in detail a cohort of 12 patients treated for a P. avidum PJI at the same 
orthopedic center. 
 
Clinical characteristics of patients with P. avidum PJI  
The median age of our 12 patients (seven females) was 61 years at the time of 
diagnosis. Nine out of 12 patients (75%) with a P. avidum PJI were obese with a BMI 
higher than 30 kg/m2 (Table 1 and Supplementary Table 1). All patients presented 
with pain, six with wound secretion or sinus tract formation, and four with local signs 
of inflammation, such as skin erythema and swelling. Fever was reported in four 
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patients. In four patients with a preoperative MRI, periprosthetic soft-tissue abscess 
and joint effusion were observed, with communication between the abscess and the 
joint effusion (Figure 2, Supplementary table 1); a further two cases (number 2 and 4) 
showed osteomyelitis of the acetabulum. The majority of infections (75%) was 
delayed (i.e. presenting one month and later after joint surgery).  
Diagnosis was confirmed preoperatively in five patients with ≥ three minor 
criteria according to MSIS PJI definition criteria [5, 18]. Among the 11 cases in which 
a pre-operative puncture of synovial fluid had been performed, P. avidum was 
cultivated from seven (63.6%) of the patients. Five of these patients (71.4%) showed 
elevated leucocytes > 3,000 cells/µl (range 8,000-308,000 cells/µl) in the synovial 
fluid cell, and six (85.7%)  80% neutrophil granulocytes (Table 2). PJI was found to 
be monomicrobial in eight and polymicrobial in four patients (Table 2).  
All but one of the 12 P. avidum strains were susceptible to clindamycin, 
levofloxacin, and rifampin (Table 3). In one patient, we found that the initially isolated 
strain was resistant to clindamycin and six months later, after levofloxacin and 
rifampin treatment, also resistant to ciprofloxacin and levofloxacin. Following surgical 
debridement or exchange of the prosthesis, all patients were treated intravenously for 
approximately two weeks with a beta-lactam (or vancomycin in case of allergies), 
followed by an oral therapy. Oral treatment and its duration was chosen according to 
MIC values and the surgical approach adopted, respectively. Thus antibiotics were 
given for a total of three months for Debridement-Antibiotics-Irrigation-Retention 
(DAIR) as well as one-stage exchange and for six weeks for two-stage exchange.  
Six out of 12 patients were primarily treated with a complete one- or two-stage 
exchange of the prosthesis, five with a DAIR procedure, and one with antibiotics 
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alone. In all but one of the six patients treated with either an initial DAIR or antibiotic 
alone, treatment failed necessitating a two-stage revision of the prosthesis with a 
good clinical outcome.  
 
Phenotypic analysis of Propionibacterium avidum strains from a cluster of PJI  
Hemolysis and biofilm production. The P. avidum strains isolated from a cluster of 
PJIs in our clinic in 2015 showed a strong hemolytic reaction, which was significantly 
greater than that of the P. acnes strains isolated from other hip PJIs (Figure 3A, p = 
0.01). The ratio of biofilm to total mass of the P. avidum strains was, however, not 
significantly different from the P. acnes strain ATCC 11827 [8] (Figure 3B).  
 
Whole genome sequencing and phylogenetic analysis. In one of the four patients 
presenting with a PJI in 2015, we detected two phenotypically different P. avidum 
strains (CI853 and CI855). To characterize the genetic diversity of our five PJI P. 
avidum strains, and therefore determine their relatedness, we performed whole 
genome sequencing followed by phylogenetic analysis; publically available P. avidum 
genomes from two PJIs (T13, T14, T15) and five various non-PJI sources (MJR7694, 
44067, ATCC25577, TM16, UCD/PD2) were also included for comparison. Illumina 
sequencing generated draft genome sequences which consisted of 69-106 contigs 
depending on the strain considered (Table 4). All five strains had almost identical 
G+C content (63.4-63.5%) and genome sizes ranging from 2.48-2.54 Mbp (Table 4). 
A total of 172 genomic regions totaling 2.1 Mbp were found to be shared among the 
13 P. avidum strains.  
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Comparison of the core genomic regions showed that CI853 and CI855, which 
were isolated from the same patient, differed only by a single SNP, and CI828, CI882 
and CI878, which were isolated from three different patients, similarly displayed a 
very high degree of relatedness to each other with 99.6%-99.8% identity at SNP sites 
(Figure 4). CI828, CI878 and CI882 also clustered together with the recently 
described P. avidum T13 and T15 strains recovered from patients with a hip PJI in 
Sweden. CI853 and CI855 were found to be similar to a further PJI strain also 
isolated in Sweden (T14) (89.9% SNP identity). Compared with an average identity of 
55.1% among the five non-PJI strains at these sites, this high degree of similarity 
suggests that the isolates within each group may be clonal. All the sequenced strains 
harbored a gene cluster encoding exopolysaccharide synthesis (EPS) as previously 
described (Figure 5) [14], as well as genes involved in survival, fitness and defense.  
 
Discussion 
This is the first clinical study describing a large cohort of patients with PJI due to the 
skin commensal P. avidum. We observed that P. avidum was predominantly 
diagnosed in association with hip arthroplasty (85%). This is in contrast to published 
data on P. acnes, which mainly causes shoulder PJI infections (prosthesis and post 
arthroscopy-related) but rarely hip infections [6]. We interpreted these results as a 
consequence of preferential skin colonization by P. avidum of sweat glands in the 
moist groin and perianal regions [19] and contrast to relatively low abundance on the 
face [20]. As we found P. avidum PJI predominantly in the hip of obese patients, we 
hypothesize that this association results from P. avidum overgrowth in the moist skin 
folds typically found in the groin region of obese individuals. This may facilitate their 
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entry into the surgical wound, even after pre-operative skin antisepsis, leading to 
downstream infection.  
Synovial fluid analysis showed a high number of leukocytes and a positive 
culture for P. avidum in 67% of cases. Thus in contrast to P. acnes, pre-operative 
differentiation of septic from aseptic-loosening of the prosthesis was much easier 
[21]. Debridement in conjunction with antibiotics was not sufficient to treat the 
infections. All five infections with a delayed presentation, and treated with 
debridement or antibiotics alone, required a subsequent two-stage exchange of the 
prosthesis. This indicates that the surgical treatment approach in P. avidum PJI 
should be the same as that described for other bacterial species [1], i.e. when 
duration of symptoms is  3 weeks, a sinus tract is present, or the implant is already 
loose, one- or two-stage revision of the arthroplasty is required for a successful 
treatment outcome [22].  
We observed obesity as a potential risk factor for P. avidum PJI after hip 
arthroplasty. A high BMI was noted in all but one patient, which is in line with a recent 
publication describing hip PJIs due to P. avidum [16]. Overall, obesity with a BMI > 
35/kg2 or > 100kg is a risk for orthopedic infections in general [23]. Most of our 
infections were associated with hip arthroplasties. We did not observe a significant 
increase in infection when the incision approach was changed, in line with the study 
of Clauss et al. [24]; however, since the combined numbers of both studies are small, 
it is yet unclear whether the incision approach for hip arthroplasty represents a risk 
factor for PJI. In general, better characterization between P. acnes and P. avidum 
strains may be an important factor, however at our institution except for the 
introduction of MALDI in 2012 diagnostic methods remained the same.   
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While the pathogenicity of P. avidum infections is poorly understood, we found 
a more pronounced hemolytic activity by P. avidum strains as compared to P. acnes, 
in line with reports in the literature [22]. Underlying its potential importance, hemolysis 
was recently described as a “clinical marker” to better distinguish orthopedic 
infections with P. acnes versus a contaminated culture, although this association is 
controversial [39-40]. A potentially key virulence trait of P. avidum in relation to PJIs 
is its ability to form biofilms on medical implants. The extracellular polymeric matrix of 
such biofilms is different from that produced by P. acnes biofilms [25]. In addition, P. 
avidum produces a capsule that is unique and has not been described for P. acnes 
nor P. granulosum [25]. This capsule may protect against phagocytosis. In the 
genomes of all five P. avidum isolates described in this study, we identified homologs 
of an EPS-encoding island previously found to be present in P. avidum, but not other 
cutaneous propionibacteria, which may be potentially important in adherence [14]. 
This island is flanked by tRNA genes, suggesting acquisition by horizontal gene 
transfer. One PJI isolate, T14, contains an EPS island that clusters with that from the 
prostate-derived isolate TM16 [46] upon phylogenetic analysis. Thus, expression of 
this locus may be a general virulence determinant not just related to PJI. 
 Phylogenetic analysis showed that our sequenced strains formed two distinct 
clusters along with strains isolated from patients with hip PJIs in Sweden [16], and 
non-PJI strains isolated from the vaginal microbiota [26] and a skin abscess [44]. 
Currently a detailed understanding of the population genetic structure of P. avidum is 
lacking. We speculate that major phylogenetic divisions and clonal lineages of P. 
avidum with varying disease potential or ecological specialization occur, similar to 
that observed with P. acnes phylogroups I, II and III recently proposed as distinct 
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bacterial subspecies [27]. This is tentatively supported by the observation of at least 
two distinct serotypes of P. avidum with a cell wall composition that mirrors P. acnes 
types I and II [28, 29].  
 In conclusion, this is the first description of a large series of PJI caused by P. 
avidum. We show that the skin commensal P. avidum predominantly caused delayed 
PJI which were only resolved by two-stage revisions. We did not identify a specific 
risk factor for the increasing number of P. avidum PJI’s in recent years. Further 
studies evaluating skin colonization with P. avidum might help to select patients at 
higher risk for invasive P. avidum infections. 
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Tables and Figures 
Table 1. Clinical characteristics of 12 patients with PJI caused by P. avidum, either as a monomicrobial (n=8) or part of a polymicrobial 
(n=4) infection, at the time of initial surgical treatment of infection at the University Hospital Balgrist. 
Characteristics Number (%) 
Median age (range), years 61 (range 45-81) 
Female 7 (58.3) 
BMI median (range) 
 Obesity grade 1 (>30) 
 Obesity grade 2 (>35) 
 Obesity grade 3 (>40) 
34.0 (27.9-40.6) 
3 (25) 
5 (41.7) 
1 (8.3) 
Underlying joint disorder for arthroplasty 
 Degenerative 
 Trauma 
 “Head necrosis” 
 
9 (75) 
2 (16.7) 
1 (8.3) 
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Place of last arthroplasty surgery before infection 
 University Hospital of Balgrist 
 Other Hospital 
 
7 (58.3) 
5 (41.7) 
Localisation of infection 
 Hip PJI 
 Shoulder PJI 
12 
10 (83.3) 
2 (16.7) 
Signs and symptoms 
 Pain 
 Wound secretion or sinus tract 
 Swelling, skin erythema 
 Fever 
 
12 (100) 
6 (50) 
4 (33.3) 
4 (33.3) 
Time to diagnosis of infection* after last surgical revision of arthroplasty* 
 Median (range), weeks 
 
13.1 (2.3-63.2) 
Time to initial septic surgery after last surgical revision of arthroplasty  
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 Median (range), weeks  
30.2 (2.9-100.3) 
Surgical treatment 
 DAIR including partial exchange of prosthesis 
 One-stage exchange 
 Two-stage exchange 
 Antibiotic treatment only 
 
5 (41.6%) 
2 (16.7%) 
4 (33.3%) 
1 (8.3%) 
Peroral antibiotic treatment after initial i.v treatment 
 Clindamycin 
 Levofloxacin/rifampin 
 Ciprofloxacin/rifampin 
 Clindamycin/rifampin 
 
4 (33.3) 
4 (33.3) 
2 (16.7) 
2 (16.7) 
* Time to first microbiological diagnosis of P. avidum (either preoperative synovial puncture or intraoperative tissue samples) with 
confirmation of infection due to MSIS criteria [5]. DAIR, Debridement-Antibiotics-Irrigation-Retention.   
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Table 2. Diagnostic characteristics of 12 patients with PJI caused by P. avidum at time of septic surgery at the University Hospital 
Balgrist 
Nr Age, 
sex 
PJI site Preoperative Intraoperative P. avidum 
strains 
Polymicrobial infection 
[other pathogen] 
   Blood Synovial fluid Tissue biopsies Sonication fluid   
   CRP, 
ESR 
P. avidum 
growth 
Lc [% 
neutrophils] 
P. avidum 
positive/total taken  
Positive P. avidum 
[CFU/ml] in  
  
Prospective (cluster in 2015) 
1 59, f Hip 4.9, 31 Negative ND [80%] 4/6 ≥ 100 CI878 No 
2 53, f Hip 200, 103 Positive 308,000 [80%] 2/5 ≥ 100 CI882 No 
3 64, f 
Hip 
74, 82 Positive 48,800 [80%] 5/5 60 CI853, 855 No 
4 81, m 
Hip 
62.7, 82 Positive 248,000 [80%] 4/6 In broth CI828 Yes [S. aureus] 
Retrospective (1997-2014) 
5 57, f Hip 7.6, 52 Positive 8,800 [80%] 2/8 20 NA No 
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Nr Age, 
sex 
PJI site Preoperative Intraoperative P. avidum 
strains 
Polymicrobial infection 
[other pathogen] 
   Blood Synovial fluid Tissue biopsies Sonication fluid   
   CRP, 
ESR 
P. avidum 
growth 
Lc [% 
neutrophils] 
P. avidum 
positive/total taken  
Positive P. avidum 
[CFU/ml] in  
  
6 72, f Hip 176, ND Positive ND 3/4 NA NA Yes [F. magna] 
7 45, f Hip 17, 21 Positive 38,300 [80%] 2/3 Negative NA No 
8 56, m Hip 15.2, 54 Negative 2,500 [ND]  2/4 Negative NA Yes [F. magna] 
9 65, f Hip 14, 37 Negative ND 1/5 ≥ 100 NA No 
10 69, m Shoulder 119, ND Positive ND 3/3 NA NA No 
11 56, m Shoulder 38/ND Negative ND 1/4 ≥ 100 NA No 
12
 
63, f Hip 95/ND ND ND 0/7
* 
20 and 27 NA Yes [S. epidermidis] 
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f, female; m, male; S. aureus, Staphylococcus aureus; S. epidermidis, Staphylococcus epidermidis; F. magna, Finegoldia magna; ND, 
not done (possible reasons include dry aspirate or hemolytic sample); NA, not available; Lc, leucocytes, ESR, erythrocyte 
sedimentation rate 
* Diagnosis of P. avidum PJI was based on clinical presentation of sinus tract as well as previous growth of P. avidum in another 
hospital.  
Manuscript prepared for CID 
 
28 
 
Table 3. MIC50 and resistance pattern of 12 P. avidum strains from PJIs using 
EUCAST breakpoints for Gram-positive anaerobes.  
Antibiotic Samples 
(Nr) 
MIC50 (range) 
(mg/l) 
MIC breakpoint (mg/l) 
   EUCAST Resistant (%) 
   S ≤ R >  
Penicillina 5 0.064 (0.03 - 0.125) 0.25 0.5 0 (0%) 
Clindamycina 12 0.032 (<0.016 - 
>256) 
4 4 1 (8.3%) 
Ciprofloxacinb 12 0.25 (0.19 - >32) 0.5 1 1 (8.3%) 
Levofloxacinb 10 0.125 (0.094 - >32) 1 2 1 (10%) 
Rifampin 12 0.004 (0.003 - 
0.008) 
-  -   
Cefuroximeb 4 0.38 (0.38 – 0.5) 4 8 0 (0%) 
MIC50, minimal inhibition concentration (median); EUCAST clinical breakpoints in 
mg/l (Table v. 6.0, valid from 2016-01-01) are shown for Gram-positive anaerobesa. If 
no clinical breakpoints for Gram-positive anaerobes exist, breakpoints from 
pharmacokinetic/pharmacodynamic (PK/PD) data (non-species related)b were taken 
[30].   
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Table 4. Genome assembly characteristics of P. avidum PJI isolates compared in 
this study. 
Strain Accession* 
Assembly 
Coverage 
Size (Mb) Contigs Genes Proteins GC% 
ATCC 25577 AGBA01 29× 2.55 7 2,290 2,200 63.3 
44067 CP005287.1 375× 2.53 1 2,297 2,184 63.5 
CI 853 NBIS00000000 114× 2.53 105 2,394 2,224 63.5 
CI 855 NBIR00000000 219× 2.54 106 2,406 2,227 63.5 
CI 828 NBIQ00000000 249× 2.48 76 2,313 2,152 63.4 
CI 882 NBIP00000000 327× 2.50 69 2,360 2,182 63.4 
CI 878 NBIO00000000 190× 2.54 89 2,422 2,251 63.4 
MJR7694 LRVD01 76× 2.47 16 2,235 2,118 63.4 
TM16 AOUA01 34× 2.54 420 2,441 2,133 63.4 
UCD-PD2 LYSN01 76× 2.67 51 2,442 2,304 63.4 
T13 LLJH01 50× 2.46 15 2,223 2,109 63.4 
T15 LLJJ01 50× 2.46 14 2,223 2,110 63.4 
T14 LLJI01 50× 2.52 9 2,290 2,184 63.4 
*NCBI WGS accession number. For 44067 the NCBI Nucleotide accession number is shown. 
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Figure legends 
Figure 1. Incidence and localization of P. avidum PJI among all patients treated at 
the University Hospital Balgrist at the time of diagnosis (1997 and 2015). 
Figure 2. Spectrum of MRI findings of four patients with P. avidum PJIs. A and B: A 
81-year old male patient (patient number 4, see Figure 1) two years after total hip 
arthroplasty of the right hip. Coronal image demonstrates joint effusion (thin arrow) 
adjacent to the neck of the prosthesis and osteomyelitis (outline arrowhead) of the 
acetabulum. Axial image in the same patient shows large soft-tissue abscess (outline 
arrows) anterior to the hip joint breaking through the superficial muscle fascia (black 
arrowhead). C and D: 53-year old female patient (patient number 2) 6 months after 
THA of the left hip. Coronal image demonstrates joint effusion (thin arrow), and 
extensive bone marrow edema in the acetabulum consistent with osteomyelitis 
(outline arrowhead). Further, extension of the infection into the soft tissue of the 
pelvis is seen (#). Axial image after intravenous gadolinium administration at the level 
of the middle third of the femoral shaft shows anterior intramuscular abscess (broad 
solid arrow) and epifascial abscess (outline arrows) extending to the dermis, with 
typical peripheral contrast enhancement. E: 59-year old female patient 2 years after 
THA of the right hip with soft tissue abscess (outline arrow) along the anterior 
surgical approach, extending to the femoral neck. F: 64-year old female patient 
(patient number 1) 19 days after THA of the right hip with soft-tissue abscess (outline 
arrow) along the anterior surgical approach, extending to the femoral neck. 
Manuscript prepared for CID 
 
31 
 
Note ‒ Asterisk, femoral component of THA; STIR, Short Tau Inversion Recovery; 
SEMAC, slice-encoding for metal artifact correction; WARP, optimized inversion 
pulse; T1, T1-weighted; fs, fat-saturated; hiBW, high readout bandwidth. 
Figure 3. Phenotypic characterization of P. avidum strains isolated in 2015 from hip 
PJIs (CI 828, CI 853, CI 878, CI 882). Panel A) Hemolysis activity of four P. avidum 
strains compared to four P. acnes strains on Brucella agar zone diameter (mm) 
measured (unpaired t-test, Mann-Whitney test) using serial dilution from a starting 
inoculum of 2-5 x 108 CFU/ml. Panel B) Biofilm formation of four P. avidum PJI 
strains compared to the P. acnes biofilm strain ATCC 11827 using a static biofilm 
assay (unpaired t-test, Mann-Whitney test). Data shown are from three experiments 
done in technical triplicates.  
Figure 4. A neighbor-joining phylogenetic tree constructed on the SNPs in the core 
genome regions of the P. avidum strains, including five P. avidum strains isolated 
from four patients with PJI described in this study (CI828, CI853, CI855, CI878, 
CI882), and previously sequenced strains (T13, T14, T15, ATCC25577, UCD-PD2, 
MJR7694, 44067, and TM16). Horizontal bar represents p-distances based on 
substitutions at the SNP sites. Bootstrap values are based on 500 replicates. 
Figure 5. A neighbor-joining phylogenetic tree constructed based on nucleotide 
differences within the P. avidum-specific EPS-encoding genomic island of 13 
sequenced P. avidum strains. Horizontal bar represents p-distances based on 
substitutions at 16,217 positions aligned across all strains. Bootstrap values are 
based on 500 replicates. 
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Figure 1 
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